Coming with step - by - step instructions (see the Our Lungs Our Mob resource), they aim to provide culturally relevant and appropriate tools and resources to combat lower screening and
later diagnosis rates among Aboriginal and Torres Strait Islander people that have been limiting their options for treatment and contributing to higher mortality rates.
Not exact matches
A major reason for poor survival
rates is
late diagnoses, by which time the cancer cells have spread to secondary sites.
The high mortality
rate is mainly due to
late diagnosis of the disease, when it is already in an advanced stage.
They found that patients with Medicaid were also more likely to be diagnosed with
late - stage cancer and have worse survival
rates than those with private insurance, although they had better
diagnoses and outcomes than uninsured women.
The mortality
rate for men is 42 % greater than for women because of
late diagnosis.
The report also finds that compared to non-Hispanic whites, Hispanic / Latino Americans have a
later stage of
diagnosis for many cancers, including breast and melanoma and have generally similar 5 - year survival, except for melanoma, for which survival
rates are lower in Hispanic compared to non-Hispanic white men (79 % versus 87 %) and women (88 % versus 92 %).
Their facts are sourced from Lyme patients and respected institutions to provide easy - to - understand details that can help a patients from prevention,
diagnosis & symptoms, to updates on the
latest treatment protocols that have had the most proven
rates of success.
A
diagnosis becomes a pre-existing condition and can be used to prevent clients from getting cheaper life and health insurance
rates later in life.
• a
later diagnosis compared to non-Indigenous people • a slower uptake of anti-retroviral treatments • less access to experienced physisicans • higher morbidity • shorter survival times • a mortality
rate three times higher than non-Indigenous people.
Menzies says a number of factors may be behind the higher death
rates, including
later diagnosis, reduced uptake of or access to treatment, greater comorbidities, and higher
rates of more aggressive cancers.
The
rates of
late diagnosis of cancer are set to increase dramatically as further barriers to primary health care are increased through co-payments.
As a consequence,
late diagnosis of cancer is far more common among Aboriginal and Torres Strait Islander than other Australians, with this leading to poor cancer outcomes, including higher
rates of mortality.